Camena Bioscience is a series a startup based in United Kingdom. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Camena Bioscience is a biotechnology company specializing in DNA synthesis. Their gSynth platform aims to provide long and complex DNA sequences with high accuracy and speed, enabling advancements in various fields such as drug discovery and synthetic biology.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky